Discount agreements for medicinal products effective from 01.04.2026 for various active substances within an open-house procedure
AOK NordWest, HagenTED 116143-2026
value not stated11 lots
Fri 4 Feb17:00 in Berlin
463days
Public tenders in Germany
7,249 open tenders
CountryTenderValueClosesDays left
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Ciclesonid, ATC R03BA08, for the period 01.04.2026 – 31.03.2027 (plus extension option of 1x12 months)
DAK-Gesundheit, HamburgTED 111527-2026
€11 lot, 1 year
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lanreotide, ATC H01CB03, for the period 01.04.2026 - 31.03.2027 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 115409-2026
€11 lot, 1 year
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to §130a Abs. 8 SGB V for the active substance Dexamethasone (exclusively dosage form IMP), ATC S01BA01, for the period 01.04.2026 - 31.03.2028
DAK-Gesundheit, HamburgTED 115975-2026
€11 lot, 2 years
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Galcanezumab, ATC N02CD02, for the period 01.04.2026 – 31.03.2028
DAK-Gesundheit, HamburgTED 114799-2026
€11 lot, 2 years
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Interferon beta-1, ATC L03AB08, for the period 01.04.2026 - 31.03.2028
DAK-Gesundheit, HamburgTED 116153-2026
€11 lot, 2 years
Sat 5 Feb12:00 in Berlin
464days
Open framework agreement on drug discounts pursuant to § 130a Abs. 8 SGB V with the possibility of joining at any time, so-called approval model 2026-03
Deutsche Rentenversicherung Knappschaft-Bahn-See, Verwaltungsgebäude Trimontepark 2/3, Wasserstr. 215TED 354716-2026
value not stated4 lots
Sat 5 Feb23:59 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active ingredient Tolvaptan excluding medicines with uniform potencies (ATC-code: G04BX21)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 186022-2026
value not stated1 lot
Sat 26 Feb12:00 in Berlin
485days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active ingredient Fentanyl in all dosage forms, excluding matrix patches and tablets (ATC-code: N02AB03)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 162227-2026
value not stated1 lot
Sat 26 Feb12:00 in Berlin
485days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the active substance Botulinumtoxin Type A (ATC Code: M03AX21).
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 188093-2026
value not stated1 lot
Sat 26 Feb12:00 in Berlin
485days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the combination of active substances betamethasone and calcipotriol in all dosage forms, except ointments and gels (ATC Code: D05AX22).
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 189625-2026
value not stated1 lot
Sat 26 Feb12:00 in Berlin
485days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for medicines with the active ingredient Follitropin alfa (ATC-code: G03GA05)
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 187208-2026
value not stated1 lot
Sat 26 Feb12:00 in Berlin
485days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the active substance Palonosetron (ATC Code: A04AA05).
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 187809-2026
value not stated1 lot
Sat 26 Feb12:00 in Berlin
485days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the active substance Fampridine (ATC Code: N07XX07).
AOK Niedersachsen. Die Gesundheitskasse., HannoverTED 190341-2026
value not stated1 lot
Sat 26 Feb12:00 in Berlin
485days
Medicinal products with the active substance Ranibizumab (ATC: S01LA04)
AOK Sachsen - Anhalt, MagdeburgTED 159932-2026
value not stated1 lot, 2 years
Tue 29 Feb
488days
Medicines with the active substance Eptinezumab (ATC: N02CD05)
AOK Sachsen - Anhalt, MagdeburgTED 199386-2026
value not stated1 lot, 2 years
Tue 29 Feb
488days
Medicinal products with the active substance Aflibercept (ATC: S01LA05 - excluding 114, 3 mg/ml)
AOK Sachsen - Anhalt, MagdeburgTED 161559-2026
value not stated1 lot, 2 years
Tue 29 Feb
488days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a para. 8 SGB V via an Open-House model for the active substance Sultamicillin (WHO ATC code: J01CR04)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 845306-2025
value not stated1 lot
Tue 29 Feb23:58 in Berlin
488days
Conclusion of non-exclusive drug discount agreement pursuant to § 130a para. 8 SGB V via an Open-House model for the active substance Solifenacin/Tamsulosin (WHO ATC code: G04CA53)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 856012-2025
value not stated1 lot
Tue 29 Feb23:58 in Berlin
488days
Open-House Biologicals Discount Agreements 2026-01 - Abaloparatide
Techniker Krankenkasse, HamburgTED 62082-2026
value not stated1 lot
Tue 29 Feb23:58 in Berlin
488days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.